Dr Glassman Takes On New Education Role

Therapeutic Solutions International, Inc. Announces the Appointment of Dr. Barry Glassman as Vice President of Training and Education. Therapeutic Solutions are suppliers of the Migran-X® and AMPSA CS® known in the UK as SCi™. 

Dr. Glassman maintains a private practice which is limited to chronic pain management, temporomandibular joint dysfunction and dental sleep medicine. He is a Diplomate of the American Academy of Craniofacial Pain and the American Academy of Pain Management, as well as a Fellow of the International College of Craniomandibular Orthopedics and the Academy of Dentistry International, and he is on the staff at the Lehigh Valley Hospital (Allentown, Pennsylvania) where he serves as a resident instructor of Craniofacial Pain and Dysfunction and Dental Sleep Medicine.

"This appointment of Dr. Glassman as Vice President of Training and Education for Therapeutic Solutions International will allow us to provide quality training for AMPSA products worldwide," stated Tim Dixon, CEO of Therapeutic Solutions International, who added, "Dr. Glassman is a popular and dynamic speaker on both the National and International lecture circuits and will bring world class education and training to AMPSA customers."

Dr. Glassman said, "Anterior Midpoint Stop Appliances (AMPSA) have become the keystone to our chronic pain practice. We have learned how these appliances can benefit general dentists and with minimal training and how incredibly helpful they are for patients."

Dr. Glassman added, "AMPSA therapy can be extremely effective for many Orofacial pain conditions including headache and migraine. I look forward to the opportunity to educate dentists worldwide as they learn the expanding role they can play in their patients' health. Therapeutic Solutions International is a forward looking company with which I am proud to be associated. I look forward to its growth as it plays a major role in health care worldwide."

Matt Everatt, Technical Director of S4S (UK) Ltd commented "The appointment of Dr Glassman by Therapeutic Solutions is fantastic news. We have worked with TSI for over 5 years and their commitment and passion to the dental industry is second to none. Dr Glassman has been over to the UK to lecture to our S4S clients for the past two years. The feedback from delegates speaks volumes about Dr Glassman and his knowledge of these contentious subject of occlusion, bruxism, TMD and chronic pain management." Matt went on to say, "Dr Glassman is by far the best speaker I have had the pleasure of listening to, his exhilarating style of presenting is so refreshing. We are delighted for Dr Glassman and very proud to have him back in the UK this October for what will be another round of Myth busting, straight talking lectures." 

Dr. Glassman has been a speaker at the Academy of Pain Management, the International College of Craniomandibular Disorders, the Academy of Orofacial Pain, the Academy of Craniofacial Pain, the International Academy of Gnathology, the American Equilibrium Society, and the American Academy of Dental Sleep Medicine. His topics include headache, chronic pain, joint dysfunction, and sleep disorders.

Dr. Glassman has had a number of articles on pain management and sleep disorders published in both peer and non-peer reviewed journals. His editorials and articles on joint dysfunction, appliance therapy, and sleep disorders have appeared in Cranio, Inside Dentistry, Pain Management, and others.

Dr. Glassman is the recipient of the prestigious Haden-Stack award, given by the American Academy of Craniofacial Pain for his dedication to education. His courses are well known for their evidence based concepts taught in an evidence based educational method that encourages understanding versus memorization. This greatly increases the likelihood of the attendee moving forward with implementation of the material.

About Therapeutic Solutions International, Inc.

Therapeutic Solutions International, supplier of SCi appliances to S4S, is a global manufacturer of the chairside anterior midpoint stop appliance (AMPSA) devices marketed internationally under the trade names Migran-X® and AMPSA CS®, known in the UK SCi™ and distributed by S4S, which have helped countless patients prevent debilitating migraine and tension headache pain, bruxism, clenching, grinding, and TMJ disorders. The Migran-X® and AMPSA CS® devices are the most effective non-drug US FDA cleared dental method of migraine prevention on the market today. Dentists fit the AMPSA devices on patients for the treatment of medically diagnosed migraine pain, as well as migraine associated tension-type headaches, in order to reduce their migraine signs and symptoms through the reduction of trigeminally innervated muscular activity, and to prevent bruxism and TMJ syndrome through the reduction of trigeminally innervated muscular activity. In clinical trials reviewed by the US FDA, 82% of medically diagnosed migraine sufferers using the Migran-X device averaged a 77% average reduction of migraine events in the first eight weeks of use. Successful outcomes are produced by reducing head, neck and jaw muscle contraction intensity by nearly 70%. Therapeutic Solutions International also licenses laboratories to manufacture and sell semi-custom AMPSA devices internationally. The Company is also a provider of continuing education programs in the United States focused on AMPSA devices. The Company's corporate website is www.therapeuticsolutionsint.com. 

Comment